It's easy to blame Shkreli for the high price, but it's also the government's fault.
They have made it so difficult for a company to get FDA approval with the red tape and the cost, the result is a market with no competition, which ends up with high prices.
1 comment
[ 5.2 ms ] story [ 15.0 ms ] threadThey have made it so difficult for a company to get FDA approval with the red tape and the cost, the result is a market with no competition, which ends up with high prices.